SMTL ID : 2fqi.1

dual binding modes of a novel series of DHODH inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: R.244, V.246, H.247 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.244, A:H.247 SO4.5: 3 residues within 4Å: Chain A: A.218, G.219, R.221 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.219 Water bridges: A:L.220, A:R.221 Salt bridges: A:R.221

3 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 4 residues within 4Å: Chain A: D.310, T.313, Q.314, R.317 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:D.310, A:Q.314 Water bridges: A:Q.314 Salt bridges: A:R.317 ACT.3: 6 residues within 4Å: Chain A: Q.167, A.168, T.171, L.204, A.205, D.206 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:Q.167 ACT.4: 4 residues within 4Å: Chain A: H.85, R.245, V.246, R.248 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:H.85

1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)

FMN.6: 24 residues within 4Å: Chain A: A.94, A.95, G.96, K.99, G.118, S.119, N.144, Y.146, N.180, N.211, K.254, T.282, N.283, T.284, S.304, G.305, L.308, V.332, G.333, G.334, L.354, Y.355, T.356 Ligands: ORO.7 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:N.144, A:Y.146, A:Y.355, A:Y.355 Hydrogen bonds: A:A.95, A:K.99, A:S.119, A:S.119, A:N.180, A:K.254, A:K.254, A:N.283, A:S.304, A:G.305, A:G.334, A:Y.355, A:T.356, A:T.356 Water bridges: A:A.95, A:G.333, A:V.335, A:V.335, A:A.357

1 x ORO: OROTIC ACID(Non-covalent)

ORO.7: 13 residues within 4Å: Chain A: K.99, N.144, R.145, Y.146, G.147, F.148, N.211, S.214, P.215, N.216, N.283, T.284 Ligands: FMN.6 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:F.148 Hydrogen bonds: A:N.144, A:N.144, A:N.144, A:Y.146, A:G.147, A:F.148, A:N.211, A:N.216, A:N.283, A:N.283, A:T.284 Water bridges: A:S.214, A:S.214 Salt bridges: A:K.99

1 x ILH: 2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID(Non-covalent)

ILH.8: 20 residues within 4Å: Chain A: Y.37, L.41, M.42, L.45, Q.46, P.51, A.54, H.55, A.58, F.61, T.62, L.66, L.67, F.97, V.133, R.135, Y.355, L.358, T.359, P.363 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.51, A:H.55, A:A.58, A:L.67, A:V.133, A:Y.355, A:T.359, A:P.363 Hydrogen bonds: A:Q.46 Salt bridges: A:R.135 Halogen bonds: A:L.66

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baumgartner, R. et al., Dual binding mode of a novel series of DHODH inhibitors. J.Med.Chem. (2006)

Release Date

2007-01-23

Peptides

Dihydroorotate dehydrogenase, mitochondrial: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dihydroorotate dehydrogenase, mitochondrial

Related Entries With Identical Sequence